VIPShop pays $112 million for controlling stake in cosmetics e-store

Chinese flash sales site VIPShop (NYSE:VIPS) has paid $112.5 million in cash to acquire a majority stake of cosmetics e-store Lafaso. The deal boosts VIPShop in the lucrative e-commerce niche serving fashion products to China’s middle-income female consumers.
According to an email sent out by Lafaso CEO Li Jing to the startup’s staff, the deal is a “marriage” to VIPShop, which is a “powerful strategic investor” in the e-store. After starting out selling cosmetics, the site now also sells women’s clothing, accessories, and jewelry.
Lafaso is more than just an e-commerce business. Aside from selling products from the likes of Lancome and L’Oreal, it also has its own cosmetics and skincare brands with names like JSkin, JCare, and JMIXP. Li Jing, one of China’s top female tech entrepreneurs, has been canny in appearing on Chinese talk shows to show off the site’s own-brand wares.

Lafaso CEO Li Jing (Image: iHeima)
VIPShop IPO’d in March 2012. After a quiet start on the stock markets, where it debuted at $6.50 per share, the flash sales site has rocketed to $114.56 at the close of yesterday’s trading. It now has a market cap of $5.8 billion. So much for the analysts who thought that the stock was doomed. VIPShop has yet to confirm the Lafaso deal. Sequoia Capital has previously invested in both companies.
(Sources: Tencent Tech and 36Kr)
(Editing by Josh Horwitz)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
Recommended reads
Forrest Li on scaling Sea, building smarter bots, and founder grit
SGX’s CEO says it doesn’t need a unicorn to win
SMEs want AI too, but not the kind Big Tech is selling
Oatside’s alt-milk rise hits a profitable gear
Alibaba’s financial health in 12 charts
Asia’s telcos bundle AI into mobile plans. Will it pay off?
M-Daq chases bigger clients as revenue falls, losses grow
VC tracker: Accel raises US$3.5b, including US$550m for India
Graas buys Temasek-backed Trustana in agentic commerce push
Doctor Anywhere posts healthier operations in 2025

